MarketPeel
Insider Trading Intelligence
Pricing
…
JH

Jeryl L. Hilleman

NVCR
DIRECTOR · NOVOCURE LTD · CIK 0001216628
FILING MIX · LIFETIME78%/22%
BUYS
31
SELLS
9
TOTAL VALUE
$1.07M
COMPANIES
4
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
108,262
AVG SELL PX
$57.38
TRADE KIND
SHOWING 40 / 40
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jeryl L. Hilleman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+57.14%-1.80%-0.53%-1.27%-2.12%—
14d7+42.86%-0.32%+1.29%-1.61%-0.38%—
30d7+57.14%-3.75%+2.26%-6.01%-7.72%—
60d7+57.14%-10.08%+5.34%-15.42%-24.88%—
90d7+71.43%-7.84%+4.86%-12.70%-21.19%—
180d7+71.43%-13.25%+8.72%-21.97%-36.38%—
1y7+71.43%-21.98%+16.79%-42.44%-62.18%—
2y7(1 pending)+100.00%-37.32%+29.91%-67.22%-68.54%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NVCR · 25,471 shares · as of Jun 3, 2026
06,36812,73619,10325,471202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 31 buys / 9 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
OMDA
OMADA HEALTH, INC.
PURCHASEGRANT
Stock grant
1,299——26,519Jul 5, 2026Jul 7, 2026 ↗View →
OMDA
OMADA HEALTH, INC.
PURCHASEGRANT
Stock grant
10,882——25,220Jun 16, 2026Jun 18, 2026 ↗View →
SIBN
SI-BONE, INC.
PURCHASEGRANT
Stock grant
10,957——43,772Jun 4, 2026Jun 9, 2026 ↗View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
11,610——25,471Jun 3, 2026Jun 5, 2026 ↗View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
16,999——16,999Jun 3, 2026Jun 5, 2026 ↗View →
NVCR
NOVOCURE LTD
SALE
2,945$15.77$46.4K13,861Jun 2, 2026Jun 3, 2026 ↗View →
OMDA
OMADA HEALTH, INC.
PURCHASEGRANT
Stock grant
1,544——14,338Apr 5, 2026Apr 7, 2026 ↗View →
OMDA
OMADA HEALTH, INC.
PURCHASEGRANT
Stock grant
1,601——12,794Jan 5, 2026Jan 7, 2026 ↗View →
OMDA
OMADA HEALTH, INC.
PURCHASEGRANT
Stock grant
1,126——11,238Oct 5, 2025Oct 7, 2025 ↗View →
OMDA
OMADA HEALTH, INC.
PURCHASEGRANT
Stock grant
1,081——11,193Oct 5, 2025Dec 18, 2025 ↗View →
OMDA
OMADA HEALTH, INC.
PURCHASEGRANT
Stock grant
376——10,112Jul 5, 2025Jul 8, 2025 ↗View →
OMDA
OMADA HEALTH, INC.
PURCHASEGRANT
Stock grant
9,736——9,736Jun 5, 2025Jun 9, 2025 ↗View →
SIBN
SI-BONE, INC.
PURCHASEGRANT
Stock grant
8,675——32,815Jun 5, 2025Jun 6, 2025 ↗View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
16,697——16,697Jun 4, 2025Jun 6, 2025 ↗View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
11,215——16,806Jun 4, 2025Jun 6, 2025 ↗View →
NVCR
NOVOCURE LTD
SALE
999$17.26$17.2K5,591Jun 3, 2025Jun 4, 2025 ↗View →
SIBN
SI-BONE, INC.
PURCHASEGRANT
Stock grant
8,791——24,140Jun 26, 2024Jun 27, 2024 ↗View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
6,229——6,229Jun 5, 2024Jun 6, 2024 ↗View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
4,053——6,590Jun 5, 2024Jun 6, 2024 ↗View →
NERV
MINERVA NEUROSCIENCES, INC.
PURCHASEGRANT
Stock grant
12,500——12,500Sep 27, 2023Sep 29, 2023 ↗View →
SIBN
SI-BONE, INC.
SALE10b5-1
10b5-1 plan
2,081$28.00$58.3K15,349Jun 20, 2023Jun 20, 2023 ↗View →
SIBN
SI-BONE, INC.
SALE10b5-1
10b5-1 plan
2,081$28.74$59.8K17,430Jun 15, 2023Jun 20, 2023 ↗View →
SIBN
SI-BONE, INC.
PURCHASEGRANT
Stock grant
4,866——19,511Jun 9, 2023Jun 13, 2023 ↗View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
12,554——12,554Jun 7, 2023Jun 9, 2023 ↗View →
SIBN
SI-BONE, INC.
PURCHASEGRANT
Stock grant
8,324——14,645Jun 16, 2022Jun 20, 2022 ↗View →
SIBN
SI-BONE, INC.
SALE
1,924$13.81$26.6K6,321Jun 13, 2022Jun 14, 2022 ↗View →
NERV
MINERVA NEUROSCIENCES, INC.
PURCHASEGRANT
Stock grant
2,500——2,500Jun 10, 2022Jun 28, 2022 ↗View →
NVCR
NOVOCURE LTD
SALE
407$69.61$28.3K2,537Jun 10, 2022Jun 16, 2022 ↗View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
8,700——8,700Jun 8, 2022Jun 10, 2022 ↗View →
SIBN
SI-BONE, INC.
SALE
4,400$33.71$148.3K8,245Jun 25, 2021Jun 30, 2021 ↗View →
NERV
MINERVA NEUROSCIENCES, INC.
PURCHASEGRANT
Stock grant
20,000——20,000Jun 11, 2021Jun 15, 2021 ↗View →
SIBN
SI-BONE, INC.
PURCHASEGRANT
Stock grant
3,848——12,645Jun 10, 2021Jun 14, 2021 ↗View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
1,499——1,499Jun 9, 2021Jun 11, 2021 ↗View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
814——4,214Jun 9, 2021Jun 11, 2021 ↗View →
NVCR
NOVOCURE LTD
SALE
1,270$210.01$266.7K2,944Jun 9, 2021Jun 11, 2021 ↗View →
NVCR
NOVOCURE LTD
SALE
2,500$166.40$416.0K3,400Dec 18, 2020Dec 22, 2020 ↗View →
SIBN
SI-BONE, INC.
PURCHASEGRANT
Stock grant
8,797——8,797Jun 16, 2020Jun 18, 2020 ↗View →
NERV
MINERVA NEUROSCIENCES, INC.
PURCHASEGRANT
Stock grant
20,000——20,000Jun 11, 2020Jun 12, 2020 ↗View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
2,541——5,900Jun 10, 2020Jun 12, 2020 ↗View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
5,101——5,101Jun 10, 2020Jun 12, 2020 ↗View →
Other insiders · NVCR
Loading peer insiders…
About this filer
CIK 0001216628
ROLE
Director
PRIMARY
NVCR
COMPANIES
4
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001216628DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback